IL-17A-BINDENDE FUSIONSPROTEIN

European patent · EP3738976 · In force

Register entry

Publication number
EP3738976
Application number
EP20180610
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 12, 2016
Published
Nov 18, 2020
Granted
Jul 23, 2025
Protection ends at the latest
Jan 11, 2036
Next annual fee due
Jan 31, 2027
IPC classes
C07K 14/54 (2006.01)
A61K 38/20 (2006.01)
A61K 38/00 (2006.01)
C07K 14/745 (2006.01)
A61P 1/02 (2006.01)
A61P 1/04 (2006.01)
A61P 3/06 (2006.01)
A61P 3/10 (2006.01)
A61P 9/10 (2006.01)
A61P 11/06 (2006.01)
A61P 13/12 (2006.01)
A61P 17/02 (2006.01)
A61P 17/06 (2006.01)
A61P 19/02 (2006.01)
A61P 19/10 (2006.01)
A61P 25/28 (2006.01)
A61P 27/02 (2006.01)
A61P 29/00 (2006.01)
A61P 37/02 (2006.01)
A61P 37/08 (2006.01)
Priority
EP 15150786 12.01.2015
Divided from
EP16700424
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 4, 2026

    Change

    Published in Swissreg on 04.06.2026

  2. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  3. Jul 23, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.07.2025

Parties

Holder

Affibody AB

Scheeles väg 2, 171 65 Solna, SE

Inventor

FREJD, Fredrik

112 20 Stockholm, SE

FELDWISCH, Joachim

135 42 Tyresö, SE

KLINT, Susanne

112 52 Stockholm, SE

GUDMUNDSDOTTER, Lindvi

118 64 Stockholm, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.